These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 623136
1. Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study. Helgeland A, Hjermann I, Holme I, Leren P. Am J Med; 1978 Jan; 64(1):34-8. PubMed ID: 623136 [Abstract] [Full Text] [Related]
2. Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study. Helgeland A, Leren P, Foss OP, Hjermann I, Holme I, Lund-Larsen PG. Am J Med; 1984 May; 76(5):802-5. PubMed ID: 6720727 [Abstract] [Full Text] [Related]
3. Antihypertensive drugs and blood lipids: the Oslo study. Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG. Br J Clin Pharmacol; 1982 May; 13(Suppl 2):441S-444S. PubMed ID: 7104158 [Abstract] [Full Text] [Related]
4. The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial. Staessen J. Am J Med; 1991 Mar; 90(3A):50S-54S. PubMed ID: 2006662 [Abstract] [Full Text] [Related]
5. Effects of diuretics on lipid metabolism in patients with essential hypertension. Chrysant SG, Neller GK, Dillard B, Frohlich ED. Angiology; 1976 Dec; 27(12):707-11. PubMed ID: 1078305 [Abstract] [Full Text] [Related]
6. The impact on serum lipids of combinations of diuretics and beta-blockers and of beta-blockers alone. Helgeland A. J Cardiovasc Pharmacol; 1984 Dec; 6 Suppl 3():S474-6. PubMed ID: 6208414 [Abstract] [Full Text] [Related]
7. Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients. Fogari R, Zoppi A, Malamani GD, Marasi G, Vanasia A, Villa G. Br J Clin Pharmacol; 1995 May; 39(5):471-6. PubMed ID: 7669481 [Abstract] [Full Text] [Related]
8. Effect of losartan combined with amlodipine or with a thiazide on uric acid levels in hypertensive patients. Rubio-Guerra AF, Garro-Almendaro AK, Elizalde-Barrera CI, Suarez-Cuenca JA, Duran-Salgado MB. Ther Adv Cardiovasc Dis; 2017 Feb; 11(2):57-62. PubMed ID: 27932570 [Abstract] [Full Text] [Related]
9. Changes in the lipoprotein profile during antihypertensive therapy. Helgeland A, Leren P, Kjeldsen S, Eide I, Foss OP. Acta Pharmacol Toxicol (Copenh); 1984 Feb; 54 Suppl 1():75-7. PubMed ID: 6711333 [Abstract] [Full Text] [Related]
10. [Levels of cholesterol, triglycerides, uric acid and glucose following prolonged treatment of hypertension with low and normal renin activity with hydrochlorothiazide]. Manitius J, Badzio T, Krupa-Wojciechowska B. Pol Tyg Lek; 1981 May 18; 36(20):711-3. PubMed ID: 7024946 [No Abstract] [Full Text] [Related]
11. Oslo study: treatment of mild hypertension. A five-year controlled drug study. Helgeland A, Leren P. Nephron; 1987 May 18; 47 Suppl 1():108-10. PubMed ID: 3320783 [Abstract] [Full Text] [Related]
12. Effects of losartan/hydrochlorothiazide on serum uric acid levels and blood pressure in hypertensive patients. Fujimori S, Oka Y, Ogata N, Eto K. Nucleosides Nucleotides Nucleic Acids; 2011 Dec 18; 30(12):1030-4. PubMed ID: 22132952 [Abstract] [Full Text] [Related]
13. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril. Middeke M, Richter WO, Schwandt P, Holzgreve H. Int J Clin Pharmacol Ther; 1997 Jun 18; 35(6):231-4. PubMed ID: 9208337 [Abstract] [Full Text] [Related]
14. Correlates of blood pressure change in middle-aged male mild hypertensives: results from the untreated control group in the Oslo hypertension trial. The Oslo Study. Holme I, Helgeland A, Hjermann I, Leren P, Mogensen SB. Am J Epidemiol; 1988 Apr 18; 127(4):742-52. PubMed ID: 3354541 [Abstract] [Full Text] [Related]
15. Effect of losartan on serum uric acid in hypertension treated with a diuretic: the COMFORT study. Matsumura K, Arima H, Tominaga M, Ohtsubo T, Sasaguri T, Fujii K, Fukuhara M, Uezono K, Morinaga Y, Ohta Y, Otonari T, Kawasaki J, Kato I, Tsuchihashi T, COMFORT Investigators. Clin Exp Hypertens; 2015 Apr 18; 37(3):192-6. PubMed ID: 25051056 [Abstract] [Full Text] [Related]
16. Antihypertensive drugs and blood lipids: the Oslo study. Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG. J Cardiovasc Pharmacol; 1982 Apr 18; 4 Suppl 2():S222-4. PubMed ID: 6177960 [Abstract] [Full Text] [Related]
17. Interaction between serum uric acid and triglycerides in relation to blood pressure. Teng F, Zhu R, Zou C, Xue Y, Yang M, Song H, Liang J. J Hum Hypertens; 2011 Nov 18; 25(11):686-91. PubMed ID: 21160529 [Abstract] [Full Text] [Related]
18. Prazosin improves atherogenic index and inhibits the deleterious effect of dihydrochlorothiazide in patients with essential hypertension. Farsang C, Péter M, Balás-Eltes A, Fehér J. J Cardiovasc Pharmacol; 1987 Nov 18; 10 Suppl 12():S240-3. PubMed ID: 2455187 [Abstract] [Full Text] [Related]
19. Ticrynafen and hydrochlorothiazide in hypertension. Okun R, Beg M. Clin Pharmacol Ther; 1978 Jun 18; 23(6):703-11. PubMed ID: 348380 [Abstract] [Full Text] [Related]
20. Possible metabolic side effects of beta-adrenergic blocking drugs. Helgeland A, Hjermann I, Leren P, Holme I. Br Med J; 1978 Apr 01; 1(6116):828. PubMed ID: 638477 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]